pd 173074 has been researched along with Nasopharyngeal Neoplasms in 1 studies
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luan, H | 1 |
| Xu, Y | 1 |
| Fu, T | 1 |
| Luan, Y | 1 |
| Yuan, C | 1 |
1 other study available for pd 173074 and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
[FGFR1 selective inhibitor PD173074 can reduce proliferation and induce apoptosis of nasopharyngeal carcinoma].
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans | 2014 |